Pauline Siders
Psychiatric/Mental Health · Lexington, KYNPI 1578890968
Payments from drug & device makers
Across 277 payments — averaging $13.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$683
- AbbVie$594
- Bausch Health US, LLC$295
- Vanda Pharmaceuticals Inc.$252
- Takeda Pharmaceuticals U.S.A., Inc.$239
- Corium, LLC$238
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,52297%
- Education$963%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,618 in reported general payments places this provider in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 29 | $56,221 |
| RexultiBrexpiprazole | 22 | $34,474 |
| TrintellixVortioxetine Hydrobromide | 22 | $25,852 |
| Lurasidone Hcl | 48 | $23,554 |
| VyvanseLisdexamfetamine Dimesylate | 47 | $18,359 |
| OzempicSemaglutide | 16 | $15,228 |
| BelsomraSuvorexant | 24 | $10,146 |
| Lisdexamfetamine Dimesylate | 27 | $5,724 |
| PristiqDesvenlafaxine Succinate | 12 | $4,944 |
| ZoloftSertraline Hcl | 12 | $4,878 |
| AdderallDextroamphetamine/Amphetamine | 17 | $4,396 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 55 | $3,221 |
| MydayisDextroamphetamine/Amphetamine | 32 | $3,212 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 142 | $3,069 |
| KlonopinClonazepam | 11 | $2,522 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $594 | $56,22129 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse, Adderall | $239 | $48,60786 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $142 | $34,47422 claims |
| MerckBelsomra | $139 | $10,14624 claims |
| Almatica Pharma LLCSertraline Hcl | $13 | $16332 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Lexington
- Adam LooseLexington$44K
- Lauren WilliamsLexington$40K
- Laura ThomsonLexington$25K
- Laura WeddleLexington$15K
- Latoya LeeLexington$12K
- Isabel JonesLexington$9K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.